Sahadain, Julimar S.

HRN: 23-08-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2023
CEFUROXIME 750MG (VIAL)
05/20/2023
05/27/2023
IV
250mg
Q8
Intraabdominal Infection
Waiting Final Action 
06/15/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/15/2023
06/21/2023
IV
150mg
OD
Septic Shock Sec To Pcap
Waiting Final Action 
06/15/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
06/15/2023
06/28/2023
IV
60mg
OD
Septic Shock Sec To Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: